SEC Comment Letter 0000000000-23-009319 to CORCEPT THERAPEUTICS INC (CORT) (CIK 0001088856) (CORT)
CORCEPT THERAPEUTICS INC (CORT) (CIK 0001088856)
Date: Aug. 24, 2023 · CIK: 0001088856 · Accession: 0000000000-23-009319
AI Filing Summary & Sentiment
File numbers found in text: 000-50679
Letter
United States securities and exchange commission logo August 24, 2023 Joseph K. Belanoff Chief Executive Officer Corcept Therapeutics Inc. 149 Commonwealth Drive Menlo Park, CA 94025 Re:Corcept Therapeutics Inc. Definitive Proxy Statement on Schedule 14A Filed April 14, 2023 File No. 000-50679 Dear Joseph K. Belanoff: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Disclosure Review Program
Show Raw Text
United States securities and exchange commission logo
August 24, 2023
Joseph K. Belanoff
Chief Executive Officer
Corcept Therapeutics Inc.
149 Commonwealth Drive
Menlo Park, CA 94025
Re:Corcept Therapeutics Inc.
Definitive Proxy Statement on Schedule 14A
Filed April 14, 2023
File No. 000-50679
Dear Joseph K. Belanoff:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Disclosure Review Program